Skip to main content
CM

Comofi Medtech

Comofi Medtech develops a robotic surgical intervention platform that integrates advanced technologies to enhance precision in minimally invasive procedures. This platform addresses the challenges of surgical efficiency and patient outcomes by providing surgeons with improved tools for complex surgeries, such as percutaneous nephrolithotomy (PCNL).

Alo, IndiaFounded 201857K+ followers
Updated 20 months ago

Funding

$300K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Minimally invasive surgical procedures, such as percutaneous nephrolithotomy (PCNL), present challenges in terms of surgical precision, efficiency, and achieving optimal patient outcomes due to limited visualization and manual dexterity constraints. Traditional methods can lead to complications and prolonged procedure times.

Solution

Comofi Medtech offers a robotic surgical intervention platform designed to enhance the precision and efficiency of minimally invasive surgeries. The platform integrates robotics, advanced imaging, and AI to provide surgeons with improved control and visualization during complex procedures like PCNL. By combining these technologies, the platform aims to simplify surgical workflows, reduce complications, and improve patient outcomes through more accurate and less invasive interventions. The nGuide-PCNL system provides real-time guidance and navigation, allowing for precise targeting and removal of kidney stones.

Target Audience

The primary target audience includes surgeons specializing in minimally invasive procedures, urologists performing PCNL, and hospitals seeking to improve surgical precision and patient outcomes.

Features

  • Robotic-assisted surgical platform for enhanced precision and control
  • Real-time image guidance and navigation for accurate targeting
  • AI-powered algorithms for surgical planning and execution
  • Minimally invasive approach to reduce patient trauma and recovery time
  • Enhanced visualization capabilities for improved surgical outcomes
  • Integration of advanced technologies to simplify complex procedures
  • Specific application for percutaneous nephrolithotomy (PCNL) procedures
This profile is AI-generated and may contain inaccuracies.